Page last updated: 2024-11-02

phenylbutazone and Intellectual Disability

phenylbutazone has been researched along with Intellectual Disability in 1 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
GIETKA, J1
KRZAKOWSKI, Z1

Other Studies

1 other study available for phenylbutazone and Intellectual Disability

ArticleYear
[CLINICAL AND THERAPEUTIC ASPECTS OF WEBER-CHRISTIAN SYNDROME].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1964, Feb-03, Volume: 19

    Topics: Abducens Nerve Diseases; Adrenal Cortex Hormones; Genetic Diseases, X-Linked; Humans; Intellectual D

1964